Compared to Estimates, Sight Sciences (SGHT) Q4 Earnings: A Look at Key Metrics

Group 1 - Sight Sciences, Inc. reported revenue of $19.07 million for the quarter ended December 2024, reflecting a 1.7% increase year-over-year and a surprise of +0.50% over the Zacks Consensus Estimate of $18.98 million [1] - The company's EPS for the quarter was -$0.23, slightly worse than the -$0.22 reported in the same quarter last year, resulting in a -15.00% surprise compared to the consensus EPS estimate of -$0.20 [1] - Over the past month, shares of Sight Sciences have decreased by -11.8%, while the Zacks S&P 500 composite has seen a decline of -4.1%, indicating underperformance relative to the broader market [3] Group 2 - Revenue from Dry Eye was reported at $0.30 million, slightly below the estimated $0.31 million, representing a significant year-over-year decline of -81% [4] - Revenue from Surgical Glaucoma was $18.77 million, which is lower than the average estimate of $19.08 million but shows a year-over-year increase of +9.4% [4] - Gross Profit for Dry Eye was $0.16 million, exceeding the average estimate of $0.02 million, while Gross Profit for Surgical Glaucoma was $16.41 million, slightly below the average estimate of $16.49 million [4]